nodes	percent_of_prediction	percent_of_DWPC	metapath
Methantheline—Protriptyline—CYP2D6—breast cancer	0.00799	0.583	CrCbGaD
Methantheline—Protriptyline—ABCB1—breast cancer	0.00571	0.417	CrCbGaD
Methantheline—HRH2—Signaling by GPCR—AKT2—breast cancer	0.000775	0.000785	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—FGF10—breast cancer	0.000771	0.000781	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—LEPR—breast cancer	0.00077	0.00078	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—breast cancer	0.000768	0.000779	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CALCA—breast cancer	0.000751	0.000762	CbGpPWpGaD
Methantheline—CHRM1—G alpha (q) signalling events—PIK3CA—breast cancer	0.000745	0.000756	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—PIK3CD—breast cancer	0.000744	0.000755	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PDGFA—breast cancer	0.000744	0.000754	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CXCR4—breast cancer	0.000734	0.000744	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CXCL12—breast cancer	0.000734	0.000744	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—TGFBR2—breast cancer	0.000733	0.000743	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—AGTR1—breast cancer	0.000731	0.000741	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—breast cancer	0.000726	0.000736	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ITPR1—breast cancer	0.000721	0.000731	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—STAT5A—breast cancer	0.000716	0.000726	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ERBB4—breast cancer	0.000716	0.000726	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—MMP3—breast cancer	0.000716	0.000726	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ARHGDIA—breast cancer	0.000716	0.000726	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—PIK3CB—breast cancer	0.000714	0.000724	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—FST—breast cancer	0.000697	0.000707	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—SMAD4—breast cancer	0.000694	0.000703	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—IGF1R—breast cancer	0.00069	0.000699	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HEY2—breast cancer	0.000689	0.000698	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—CXCL8—breast cancer	0.000686	0.000696	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—RPS6KB2—breast cancer	0.000681	0.00069	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—TP53—breast cancer	0.000681	0.00069	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—HES1—breast cancer	0.000677	0.000687	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—NCOR1—breast cancer	0.000673	0.000683	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PLA2G4A—breast cancer	0.000673	0.000683	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—RGS2—breast cancer	0.000673	0.000682	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—breast cancer	0.000667	0.000676	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CSF2—breast cancer	0.000666	0.000675	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—FGF1—breast cancer	0.000666	0.000675	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CCL20—breast cancer	0.000665	0.000674	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—RAF1—breast cancer	0.000664	0.000674	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—AGTR1—breast cancer	0.000664	0.000673	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—NRG1—breast cancer	0.000661	0.00067	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—H2AFX—breast cancer	0.000656	0.000665	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—IL2—breast cancer	0.000656	0.000665	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—ITPR1—breast cancer	0.000656	0.000665	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—E2F1—breast cancer	0.000652	0.000661	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—PIK3CB—breast cancer	0.000649	0.000658	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TLE3—breast cancer	0.000644	0.000653	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—LPAR1—breast cancer	0.000644	0.000653	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HEY1—breast cancer	0.000638	0.000647	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—SPP1—breast cancer	0.000626	0.000635	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—DLL1—breast cancer	0.000625	0.000634	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—CXCL8—breast cancer	0.000623	0.000632	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—IL6—breast cancer	0.000623	0.000632	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ERBB3—breast cancer	0.000619	0.000628	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—FGFR2—breast cancer	0.000618	0.000627	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—breast cancer	0.000617	0.000625	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HIST1H2BK—breast cancer	0.000614	0.000622	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HIST1H2BC—breast cancer	0.000614	0.000622	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GRB7—breast cancer	0.000608	0.000617	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PDE4D—breast cancer	0.000608	0.000617	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CSF2—breast cancer	0.000606	0.000614	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TAB2—breast cancer	0.000598	0.000606	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—IL2—breast cancer	0.000596	0.000604	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—ITPR1—breast cancer	0.000596	0.000604	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—TERT—breast cancer	0.000594	0.000602	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CNR2—breast cancer	0.000593	0.000601	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—CXCL8—breast cancer	0.000593	0.000601	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—MMP3—breast cancer	0.000592	0.0006	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—breast cancer	0.00059	0.000599	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—DKK1—breast cancer	0.000579	0.000587	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—FGFR1—breast cancer	0.000576	0.000584	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—VEGFC—breast cancer	0.000574	0.000582	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—HIF1A—breast cancer	0.000568	0.000576	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—JAG2—breast cancer	0.000566	0.000573	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—WNT1—breast cancer	0.000557	0.000565	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PLA2G4A—breast cancer	0.000556	0.000564	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—LEP—breast cancer	0.000554	0.000562	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CSF2—breast cancer	0.00055	0.000558	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CAV1—breast cancer	0.000549	0.000557	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—KDR—breast cancer	0.000543	0.00055	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ESR1—breast cancer	0.000529	0.000536	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NOTCH4—breast cancer	0.000528	0.000536	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GZMB—breast cancer	0.000525	0.000533	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—FN1—breast cancer	0.000523	0.00053	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—NFKBIA—breast cancer	0.000516	0.000524	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—NOTCH1—breast cancer	0.000511	0.000518	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—AGTR2—breast cancer	0.00051	0.000517	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CXCL2—breast cancer	0.00051	0.000517	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PTHLH—breast cancer	0.000504	0.000511	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—BMP2—breast cancer	0.000504	0.000511	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PIK3CG—breast cancer	0.0005	0.000507	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—APC—breast cancer	0.0005	0.000507	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—KIT—breast cancer	0.0005	0.000507	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—EGF—breast cancer	0.000494	0.000501	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—EDNRB—breast cancer	0.000488	0.000495	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PGR—breast cancer	0.000483	0.00049	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—THBS1—breast cancer	0.000481	0.000488	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—MAPK3—breast cancer	0.000479	0.000486	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—BRAF—breast cancer	0.00047	0.000477	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—FLT1—breast cancer	0.000459	0.000465	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—IGF1—breast cancer	0.000458	0.000464	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—AKT2—breast cancer	0.000458	0.000464	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—FGF3—breast cancer	0.000457	0.000463	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—SQSTM1—breast cancer	0.000457	0.000463	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—EGFR—breast cancer	0.000456	0.000462	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—PIK3CG—breast cancer	0.000455	0.000461	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—JAG1—breast cancer	0.000451	0.000458	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PARP1—breast cancer	0.000449	0.000456	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NOTCH3—breast cancer	0.000449	0.000456	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CALCA—breast cancer	0.000444	0.00045	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PIK3CD—breast cancer	0.00044	0.000446	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—RPS6—breast cancer	0.000439	0.000445	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—PIK3CA—breast cancer	0.000435	0.000442	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—FGF4—breast cancer	0.000435	0.000441	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—SERPINE1—breast cancer	0.000435	0.000441	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CXCL12—breast cancer	0.000434	0.00044	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CXCR4—breast cancer	0.000434	0.00044	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—KRAS—breast cancer	0.00043	0.000436	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PAK1—breast cancer	0.000426	0.000431	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TCF7L2—breast cancer	0.000418	0.000424	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—AKT2—breast cancer	0.000416	0.000422	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—NOS3—breast cancer	0.000415	0.000421	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PIK3CG—breast cancer	0.000413	0.000419	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NOTCH2—breast cancer	0.000403	0.000409	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HSP90AA1—breast cancer	0.000403	0.000409	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—PIK3CD—breast cancer	0.0004	0.000405	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—PIK3CA—breast cancer	0.000395	0.000401	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—MDM2—breast cancer	0.000394	0.000399	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—RAF1—breast cancer	0.000392	0.000398	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PRL—breast cancer	0.000392	0.000398	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—AGTR1—breast cancer	0.000392	0.000398	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—RELA—breast cancer	0.000391	0.000396	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ERBB2—breast cancer	0.000388	0.000394	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—STK11—breast cancer	0.000386	0.000392	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ADAM10—breast cancer	0.000386	0.000392	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—MTOR—breast cancer	0.000383	0.000389	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PIK3CB—breast cancer	0.000383	0.000389	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PLG—breast cancer	0.000382	0.000387	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—AKT2—breast cancer	0.000378	0.000383	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—FGF10—breast cancer	0.000376	0.000381	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CXCL8—breast cancer	0.000368	0.000373	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—HRAS—breast cancer	0.000366	0.000371	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PIK3CD—breast cancer	0.000363	0.000368	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PDGFA—breast cancer	0.000363	0.000368	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CDKN1B—breast cancer	0.00036	0.000365	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TGFBR2—breast cancer	0.000358	0.000363	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—AKT1—breast cancer	0.000356	0.000361	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CASP3—breast cancer	0.000352	0.000357	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—IL2—breast cancer	0.000352	0.000357	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ITPR1—breast cancer	0.000352	0.000357	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—IL6—breast cancer	0.00035	0.000355	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MMP3—breast cancer	0.000349	0.000354	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ERBB4—breast cancer	0.000349	0.000354	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—STAT5A—breast cancer	0.000349	0.000354	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—PIK3CB—breast cancer	0.000348	0.000353	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CCND1—breast cancer	0.000343	0.000348	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—JUN—breast cancer	0.000342	0.000347	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CTNNB1—breast cancer	0.00034	0.000344	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—SMAD4—breast cancer	0.000338	0.000343	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—IGF1R—breast cancer	0.000336	0.000341	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CXCL8—breast cancer	0.000335	0.00034	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—MMP9—breast cancer	0.000333	0.000338	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CDKN1A—breast cancer	0.000332	0.000336	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PTEN—breast cancer	0.000331	0.000336	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HES1—breast cancer	0.00033	0.000335	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NCOR1—breast cancer	0.000329	0.000333	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PLA2G4A—breast cancer	0.000329	0.000333	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CSF2—breast cancer	0.000325	0.000329	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—FGF1—breast cancer	0.000325	0.000329	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—RAF1—breast cancer	0.000324	0.000329	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—MAPK8—breast cancer	0.000324	0.000328	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—AKT1—breast cancer	0.000323	0.000328	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NRG1—breast cancer	0.000322	0.000327	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—H2AFX—breast cancer	0.00032	0.000325	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—IL2—breast cancer	0.00032	0.000324	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—E2F1—breast cancer	0.000318	0.000322	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PIK3CB—breast cancer	0.000316	0.000321	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—SRC—breast cancer	0.000307	0.000311	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—SPP1—breast cancer	0.000305	0.00031	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CXCL8—breast cancer	0.000304	0.000308	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ERBB3—breast cancer	0.000302	0.000306	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—FGFR2—breast cancer	0.000302	0.000306	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—VEGFA—breast cancer	0.000299	0.000303	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—STAT3—breast cancer	0.000296	0.0003	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—IL2—breast cancer	0.000291	0.000295	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TERT—breast cancer	0.00029	0.000294	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—MAPK3—breast cancer	0.000283	0.000287	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—FGFR1—breast cancer	0.000281	0.000285	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HIF1A—breast cancer	0.000277	0.000281	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—MYC—breast cancer	0.000275	0.000279	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—TGFB1—breast cancer	0.000275	0.000278	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—LEP—breast cancer	0.00027	0.000274	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—EGFR—breast cancer	0.000269	0.000273	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CAV1—breast cancer	0.000268	0.000272	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—KDR—breast cancer	0.000265	0.000269	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ESR1—breast cancer	0.000258	0.000262	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—FN1—breast cancer	0.000255	0.000258	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—KRAS—breast cancer	0.000254	0.000258	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NFKBIA—breast cancer	0.000252	0.000255	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NOTCH1—breast cancer	0.000249	0.000253	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—APC—breast cancer	0.000244	0.000247	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—KIT—breast cancer	0.000244	0.000247	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PIK3CG—breast cancer	0.000244	0.000247	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—EGF—breast cancer	0.000241	0.000245	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—MAPK3—breast cancer	0.000234	0.000237	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PIK3CA—breast cancer	0.000234	0.000237	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—BRAF—breast cancer	0.000229	0.000233	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—TP53—breast cancer	0.000226	0.000229	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—IGF1—breast cancer	0.000223	0.000226	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—AKT2—breast cancer	0.000223	0.000226	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—EGFR—breast cancer	0.000222	0.000225	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—HRAS—breast cancer	0.000216	0.000219	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PIK3CD—breast cancer	0.000214	0.000217	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—PIK3CA—breast cancer	0.000212	0.000215	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—SERPINE1—breast cancer	0.000212	0.000215	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—KRAS—breast cancer	0.00021	0.000213	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—IL6—breast cancer	0.000207	0.00021	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NOS3—breast cancer	0.000203	0.000205	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PIK3CA—breast cancer	0.000193	0.000196	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MDM2—breast cancer	0.000192	0.000195	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—RAF1—breast cancer	0.000191	0.000194	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—AKT1—breast cancer	0.000191	0.000193	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—RELA—breast cancer	0.000191	0.000193	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ERBB2—breast cancer	0.000189	0.000192	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MTOR—breast cancer	0.000187	0.00019	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PIK3CB—breast cancer	0.000187	0.00019	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CXCL8—breast cancer	0.00018	0.000182	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—HRAS—breast cancer	0.000178	0.000181	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CDKN1B—breast cancer	0.000175	0.000178	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—AKT1—breast cancer	0.000174	0.000176	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CASP3—breast cancer	0.000172	0.000174	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—IL2—breast cancer	0.000172	0.000174	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—IL6—breast cancer	0.000171	0.000173	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CCND1—breast cancer	0.000167	0.00017	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—JUN—breast cancer	0.000167	0.000169	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CTNNB1—breast cancer	0.000166	0.000168	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MMP9—breast cancer	0.000162	0.000165	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CDKN1A—breast cancer	0.000162	0.000164	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PTEN—breast cancer	0.000162	0.000164	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MAPK8—breast cancer	0.000158	0.00016	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—AKT1—breast cancer	0.000158	0.00016	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—SRC—breast cancer	0.00015	0.000152	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—VEGFA—breast cancer	0.000146	0.000148	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—STAT3—breast cancer	0.000144	0.000146	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MAPK3—breast cancer	0.000138	0.00014	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MYC—breast cancer	0.000134	0.000136	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TGFB1—breast cancer	0.000134	0.000136	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—EGFR—breast cancer	0.000131	0.000133	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—KRAS—breast cancer	0.000124	0.000126	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PIK3CA—breast cancer	0.000114	0.000116	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TP53—breast cancer	0.00011	0.000112	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HRAS—breast cancer	0.000105	0.000107	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—IL6—breast cancer	0.000101	0.000102	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—AKT1—breast cancer	9.31e-05	9.44e-05	CbGpPWpGaD
